The U.S. Commission on Combating Synthetic Opioid Trafficking, established by the 2020 National Defense Authorization Act, has released its...
Reports
Blockchain Intelligence Group released a first-of-its-kind Cryptocurrency Compliance Playbook for the US targeting Virtual Asset Service Provider's (VASPs) and...
White Paper by Frank Breve, PharmD and Jo Ann LeQuang, BA from Opioid Consultant Solutions
Afghanistan’s ‘tablet K’ – a forensic insight into an emerging synthetic drug market
Lisa McElhaney / /The Global SMART Updates (GSU) are biannual publications of the UNODC Global Synthetics Monitoring: Analyses, Reporting and Trends (SMART)...
This report provides cumulative and updated statistics about the emergence and landscape of novel psychoactive substances (NPS) in the...
This report provides up-to-date information regarding the Drug Supply in Philidelphia, PA
Opioid Overdoses from the Toxicology Investigators Consortium (ToxIC) Fentalog Study Group – Q4 2021
Lisa McElhaney / /This report provides new information regarding comprehensive drug testing of clinical biological specimins collected after suspected opioid overdoses in...
Etodesnitazene — New Synthetic Opioid Identified During Forensic Death Investigations in the United States and Canada
Lisa McElhaney / /Purpose: The objective of this announcement is to notify public health and safety, law enforcement, first responders, clinicians, medical...
New Synthetic Opioid Protonitazene Increasing in Prevalence as “Nitazenes” Gain Traction Across the United States and Canada
Lisa McElhaney / /Purpose: The objective of this announcement is to notify public health and safety, law enforcement, first responders, clinicians, medical...
Trending Reports
- Trend Reports: cfsre NPS – Q1 2024 April 13, 2024
- NDEWS State Report: Alerts in New ork for 2023 April 12, 2024
- Federal Register: Placement of Etodesnitazene, NPyrrolidino Etonitazene, and Protonitazene in Schedule I April 11, 2024
- Federal Register: Extension of Temporary Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I April 11, 2024
- NDEWS Hotspot Alerts March 21 – 27, 2024 April 5, 2024